Global Aortic Valve Replacement Devices Market Report and Forecast 2023-2028

Global Aortic Valve Replacement Devices Market Report and Forecast 2023-2028

Market Outlook

According to the report by Expert Market Research (EMR), the global aortic valve replacement devices market is projected to grow at a CAGR of 6.8 % between 2023 and 2028. The market growth is being aided by the growing prevalence of valvular conditions, including aortic regurgitation and aortic stenosis.

In aortic valve replacement procedures, an artificial heart valve is used to replace the patient's failing aortic valve using aortic valve replacement devices. Aortic valve replacements are commonly needed in patients with valvular conditions, such as aortic regurgitation or aortic stenosis. A prosthetic or artificial valve may be used, and it may be made of synthetic materials or tissues from animals. An aortic valve replacement can help promote cardiac muscle function, reduce symptoms, and restore normal blood flow.

The rising frequency of valvular conditions is one of the major factors driving the aortic valve replacement devices market expansion. The market is also being supported by the numerous measures being taken by governments of various nations to treat valvular disorders. The expansion of the market is also significantly impacted by the increasing elderly population. The preferred procedure for extending and enhancing the quality of life for people with valvular disorders is surgical and transcatheter aortic valve replacement (TAVR). These therapeutic approaches enhance patient results and are growing in popularity.

It is anticipated that favourable reimbursement scenarios in various countries and advancements in aortic valve replacement surgery will likely favour the market growth during the forecast period. The introduction of government initiatives to assist the populace by reimbursing a portion of their medical expenses is projected to have a significant positive impact on aortic valve replacement devices market growth throughout the course of the forecast year. With availability of financial support, more patients are likely to proceed with aortic valve replacements.

Based on end use, hospitals make up a significant portion of the market for aortic valve replacement devices. The vast number of patients admitted to hospitals is the primary element sustaining the segment's dominance. This category is projected to grow quickly throughout the projection period due to the fact that hospitals are often the primary source of healthcare in developing nations. As hospitals step up their efforts to offer the public the most modern procedures and services, the market for aortic valve replacement devices is anticipated to grow over the coming few years.

Market Segmentation

The market can be divided on the basis of surgery type, product type, end use, and region.

Market Breakup by Surgery Type

• Open Surgery
• Minimally Invasive Surgery

Market Breakup by Product Type

• Transcatheter Aortic Valve
• Sutureless Aortic Valve Replacement (SUAVR)

Market Segmentation by End Use

• Hospital
• Ambulatory Surgical Centres
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Competitive Landscape

The EMR report looks into the market shares, plant turnarounds, capacities, investments, and acquisitions and mergers, among other major developments, of the global aortic valve replacement devices market companies. Some of the major key players explored in the report by Expert Market Research are as follows:

• Boston Scientific Corporation
• LivaNova PLC
• Edwards Lifesciences Corporation
• Medtronic PLC
• CryoLife, Inc.
• Others

*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.